Currently, NEUROG1 is considered a potential diagnostic marker for early CRC since its methylation status can be detected in patient sera in a non-invasive way by population-wide screening for colorectal neoplasia, which is especially useful for people who refuse colonoscopy [48]. The gene discussed is NEUROG1; the disease is colorectal carcinoma.